Physician profile
Morgan Ball
NPI 1164917902
$1,706.76
in general payments reported to CMS, 2019-2025
19 companies · $63.01 in 2025
The $63.01 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $523 · 2022: $251 · 2023: $677 · 2024: $193 · 2025: $63.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $438.67 | 2022-2025 | Wavewriter Alpha Prime 16, Infinion 16, Spectra Wavewriter |
| Teva Pharmaceuticals USA, INC. | $289.75 | 2021 | |
| Abbvie INC. | $181.92 | 2022-2023 | |
| Medtronic, INC. | $170.75 | 2021-2024 | Intellis Adaptivestim |
| Amneal Pharmaceuticals LLC | $164.68 | 2022-2023 | Lyvispah, Rytary |
| Lilly USA, LLC | $69.67 | 2022-2025 | Emgality, Mounjaro, Reyvow |
| Biogen, INC. | $69.29 | 2023 | Vumerity |
| Sk Life Science, INC. | $68.57 | 2022-2023 | |
| Averitas Pharma INC. | $40.88 | 2023 | Qutenza |
| Aprecia Pharmaceuticals, LLC | $38.78 | 2023 | Spritam |
| Almatica Pharma LLC | $29.91 | 2021 | |
| Biodelivery Sciences International, INC. | $28.30 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.01 | 2021 | |
| Lundbeck LLC | $20.02 | 2021 | |
| Vertos Medical, INC. | $16.38 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.08 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.93 | 2021 | |
| Amgen INC. | $12.50 | 2021 | |
| Allergan, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.